BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24400116)

  • 1. Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss.
    Boyle DL; Hammaker D; Edgar M; Zaiss MM; Teufel S; David JP; Schett G; Firestein GS
    PLoS One; 2014; 9(1):e84818. PubMed ID: 24400116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of p38MAPK isoforms by MKK6 and MKK3.
    Remy G; Risco AM; Iñesta-Vaquera FA; González-Terán B; Sabio G; Davis RJ; Cuenda A
    Cell Signal; 2010 Apr; 22(4):660-7. PubMed ID: 20004242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.
    Yoshizawa T; Hammaker D; Boyle DL; Corr M; Flavell R; Davis R; Schett G; Firestein GS
    J Immunol; 2009 Jul; 183(2):1360-7. PubMed ID: 19561096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
    Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
    Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
    Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
    J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of anti-inflammatory genes by p38 MAP kinase and MAP kinase kinase 6.
    Hammaker D; Boyle DL; Topolewski K; Firestein GS
    J Inflamm (Lond); 2014; 11():14. PubMed ID: 24855454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation.
    Romero-Becerra R; Mora A; Manieri E; Nikolic I; Santamans AM; Montalvo-Romeral V; Cruz FM; Rodríguez E; León M; Leiva-Vega L; Sanz L; Bondía V; Filgueiras-Rama D; Jiménez-Borreguero LJ; Jalife J; Gonzalez-Teran B; Sabio G
    Elife; 2022 Aug; 11():. PubMed ID: 35971771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice.
    Sorkin LS; Boyle DL; Hammaker D; Herman DS; Vail E; Firestein GS
    Neuroscience; 2009 Aug; 162(2):462-71. PubMed ID: 19427893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.
    Lim AK; Nikolic-Paterson DJ; Ma FY; Ozols E; Thomas MC; Flavell RA; Davis RJ; Tesch GH
    Diabetologia; 2009 Feb; 52(2):347-58. PubMed ID: 19066844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney.
    Ma FY; Tesch GH; Flavell RA; Davis RJ; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1556-63. PubMed ID: 17686961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.
    Galan-Moya EM; de la Cruz-Morcillo MA; Llanos Valero M; Callejas-Valera JL; Melgar-Rojas P; Hernadez Losa J; Salcedo M; Fernández-Aramburo A; Ramon y Cajal S; Sánchez-Prieto R
    PLoS One; 2011; 6(12):e28406. PubMed ID: 22164285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes.
    Inoue T; Hammaker D; Boyle DL; Firestein GS
    J Immunol; 2005 Apr; 174(7):4301-6. PubMed ID: 15778394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple activation mechanisms of p38alpha mitogen-activated protein kinase.
    Kang YJ; Seit-Nebi A; Davis RJ; Han J
    J Biol Chem; 2006 Sep; 281(36):26225-34. PubMed ID: 16849316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells.
    Makeeva N; Myers JW; Welsh N
    Biochem J; 2006 Jan; 393(Pt 1):129-39. PubMed ID: 16097952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.